Neurodiagnostics Market 2027 by Product, Indication, End User and Geography | The Insight Partners

Neurodiagnostics Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Product ( Diagnostic Imaging Systems, Clinical Diagnostic Instruments, Reagents and Consumables ); Indication ( Neurodegenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders ); End User ( Hospitals and Surgical Centers, Diagnostic Laboratories and Imaging Centers, Neurology Centers, Ambulatory Care Centers, Research Laboratories and Academic Institutes )and Geography

Report Code: TIPRE00008007 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Neurodiagnostics tests are carried out when a patient suffers from the central nervous system (brain and spinal cord) related diseases. The two types of neurodiagnostic testing: imaging tests or scans (x-ray, CT scan, MRI scan, PET scan) and electrical impulse detection (EEG, EMG). Neurodiagnostics helps to record, monitor, and analyze nervous system function in order to promote the effective treatment of pathologic conditions.

MARKET DYNAMICS

Neurodiagnostics market is anticipated to grow in the forecast period owing to increasing incidences of neurological disorders, a growing number of diagnostic centers, and advancements in genomics and proteomics for the diagnosis of neurodegenerative disorders. Moreover, inorganic strategies by the market players like collaborations, mergers, and acquisitions by the market players are likely to create opportunities during the forecast period.

MARKET SCOPE

The "Global Neurodiagnostics market analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of neurodiagnostics market with detailed market segmentation by product, indication, end user and geography. The global neurodiagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading neurodiagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global neurodiagnostics market is segmented on the basis of product, indication and end user. Based on product, the market is segmented as diagnostic imaging systems, clinical diagnostic instruments, reagents and consumables. Based on indication, the market is segmented as neurodegenerative diseases, epilepsy, stroke, headache disorders, and sleep disorders. The end user segment is further divided into hospitals and surgical centers, diagnostic laboratories and imaging centers, neurology centers, ambulatory care centers, research laboratories and academic institutes.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neurodiagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neurodiagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting neurodiagnostics market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the neurodiagnostics market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the neurodiagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from neurodiagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for neurodiagnostics market in the global market. Below mentioned is the list of few companies engaged in the neurodiagnostics market.

The report also includes the profiles of key neurodiagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  GE HEALTHCARE
  •  KONINKLIJKE PHILIPS N.V.
  •  SIEMENS HEALTHINEERS
  •  HITACHI, LTD
  •  CANON, INC.
  •  NATUS MEDICAL INCORPORATED
  •  F. HOFFMANN-LA ROCHE AG
  •  ADVANCED BRAIN MONITORING, INC.
  •  LIFELINES NEURO
  •  MITSAR CO., LTD

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neurodiagnostics Market - By Product
1.3.2 Neurodiagnostics Market - By Indication
1.3.3 Neurodiagnostics Market - By End User
1.3.4 Neurodiagnostics Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. NEURODIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. NEURODIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. NEURODIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. NEURODIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. NEURODIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. NEURODIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. DIAGNOSTIC IMAGING SYSTEMS
7.3.1. Overview
7.3.2. Diagnostic Imaging Systems Market Forecast and Analysis
7.3.3. MRI Systems Market
7.3.3.1. Overview
7.3.3.2. MRI Systems Market Forecast and Analysis
7.3.4. EEG Systems Market
7.3.4.1. Overview
7.3.4.2. EEG Systems Market Forecast and Analysis
7.3.5. CT Scanners Market
7.3.5.1. Overview
7.3.5.2. CT Scanners Market Forecast and Analysis
7.3.6. PET Scanners Market
7.3.6.1. Overview
7.3.6.2. PET Scanners Market Forecast and Analysis
7.3.7. EMG Devices Market
7.3.7.1. Overview
7.3.7.2. EMG Devices Market Forecast and Analysis
7.3.8. Ultrasound Imaging Systems Market
7.3.8.1. Overview
7.3.8.2. Ultrasound Imaging Systems Market Forecast and Analysis
7.3.9. MEG Devices Market
7.3.9.1. Overview
7.3.9.2. MEG Devices Market Forecast and Analysis
7.3.10. Angiography Systems Market
7.3.10.1. Overview
7.3.10.2. Angiography Systems Market Forecast and Analysis
7.3.11. Others Market
7.3.11.1. Overview
7.3.11.2. Others Market Forecast and Analysis
7.4. CLINICAL DIAGNOSTIC INSTRUMENTS
7.4.1. Overview
7.4.2. Clinical Diagnostic Instruments Market Forecast and Analysis
7.4.3. PCR Instruments Market
7.4.3.1. Overview
7.4.3.2. PCR Instruments Market Forecast and Analysis
7.4.4. NGS Instruments Market
7.4.4.1. Overview
7.4.4.2. NGS Instruments Market Forecast and Analysis
7.4.5. Sanger Sequencers Market
7.4.5.1. Overview
7.4.5.2. Sanger Sequencers Market Forecast and Analysis
7.4.6. Others Market
7.4.6.1. Overview
7.4.6.2. Others Market Forecast and Analysis
7.5. REAGENTS AND CONSUMABLES
7.5.1. Overview
7.5.2. Reagents and Consumables Market Forecast and Analysis
7.5.3. Media and Sera Market
7.5.3.1. Overview
7.5.3.2. Media and Sera Market Forecast and Analysis
7.5.4. Antibodies Market
7.5.4.1. Overview
7.5.4.2. Antibodies Market Forecast and Analysis
7.5.5. Buffers Market
7.5.5.1. Overview
7.5.5.2. Buffers Market Forecast and Analysis
7.5.6. Solvents Market
7.5.6.1. Overview
7.5.6.2. Solvents Market Forecast and Analysis
7.5.7. Enzymes Proteins Market
7.5.7.1. Overview
7.5.7.2. Enzymes Proteins Market Forecast and Analysis
7.5.8. and Peptides Market
7.5.8.1. Overview
7.5.8.2. and Peptides Market Forecast and Analysis
7.5.9. Probes Market
7.5.9.1. Overview
7.5.9.2. Probes Market Forecast and Analysis
7.5.10. Others Market
7.5.10.1. Overview
7.5.10.2. Others Market Forecast and Analysis

8. NEURODIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. NEURODEGENERATIVE DISEASES
8.3.1. Overview
8.3.2. Neurodegenerative Diseases Market Forecast and Analysis
8.4. EPILEPSY
8.4.1. Overview
8.4.2. Epilepsy Market Forecast and Analysis
8.5. STROKE
8.5.1. Overview
8.5.2. Stroke Market Forecast and Analysis
8.6. HEADACHE DISORDERS
8.6.1. Overview
8.6.2. Headache Disorders Market Forecast and Analysis
8.7. SLEEP DISORDERS
8.7.1. Overview
8.7.2. Sleep Disorders Market Forecast and Analysis

9. NEURODIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND SURGICAL CENTERS
9.3.1. Overview
9.3.2. Hospitals and Surgical Centers Market Forecast and Analysis
9.4. DIAGNOSTIC LABORATORIES AND IMAGING CENTERS
9.4.1. Overview
9.4.2. Diagnostic Laboratories and Imaging Centers Market Forecast and Analysis
9.5. NEUROLOGY CENTERS
9.5.1. Overview
9.5.2. Neurology Centers Market Forecast and Analysis
9.6. AMBULATORY CARE CENTERS
9.6.1. Overview
9.6.2. Ambulatory Care Centers Market Forecast and Analysis
9.7. RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
9.7.1. Overview
9.7.2. Research Laboratories and Academic Institutes Market Forecast and Analysis

10. NEURODIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Neurodiagnostics Market Overview
10.1.2 North America Neurodiagnostics Market Forecasts and Analysis
10.1.3 North America Neurodiagnostics Market Forecasts and Analysis - By Product
10.1.4 North America Neurodiagnostics Market Forecasts and Analysis - By Indication
10.1.5 North America Neurodiagnostics Market Forecasts and Analysis - By End User
10.1.6 North America Neurodiagnostics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Neurodiagnostics Market
10.1.6.1.1 United States Neurodiagnostics Market by Product
10.1.6.1.2 United States Neurodiagnostics Market by Indication
10.1.6.1.3 United States Neurodiagnostics Market by End User
10.1.6.2 Canada Neurodiagnostics Market
10.1.6.2.1 Canada Neurodiagnostics Market by Product
10.1.6.2.2 Canada Neurodiagnostics Market by Indication
10.1.6.2.3 Canada Neurodiagnostics Market by End User
10.1.6.3 Mexico Neurodiagnostics Market
10.1.6.3.1 Mexico Neurodiagnostics Market by Product
10.1.6.3.2 Mexico Neurodiagnostics Market by Indication
10.1.6.3.3 Mexico Neurodiagnostics Market by End User
10.2. EUROPE
10.2.1 Europe Neurodiagnostics Market Overview
10.2.2 Europe Neurodiagnostics Market Forecasts and Analysis
10.2.3 Europe Neurodiagnostics Market Forecasts and Analysis - By Product
10.2.4 Europe Neurodiagnostics Market Forecasts and Analysis - By Indication
10.2.5 Europe Neurodiagnostics Market Forecasts and Analysis - By End User
10.2.6 Europe Neurodiagnostics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Neurodiagnostics Market
10.2.6.1.1 Germany Neurodiagnostics Market by Product
10.2.6.1.2 Germany Neurodiagnostics Market by Indication
10.2.6.1.3 Germany Neurodiagnostics Market by End User
10.2.6.2 France Neurodiagnostics Market
10.2.6.2.1 France Neurodiagnostics Market by Product
10.2.6.2.2 France Neurodiagnostics Market by Indication
10.2.6.2.3 France Neurodiagnostics Market by End User
10.2.6.3 Italy Neurodiagnostics Market
10.2.6.3.1 Italy Neurodiagnostics Market by Product
10.2.6.3.2 Italy Neurodiagnostics Market by Indication
10.2.6.3.3 Italy Neurodiagnostics Market by End User
10.2.6.4 Spain Neurodiagnostics Market
10.2.6.4.1 Spain Neurodiagnostics Market by Product
10.2.6.4.2 Spain Neurodiagnostics Market by Indication
10.2.6.4.3 Spain Neurodiagnostics Market by End User
10.2.6.5 United Kingdom Neurodiagnostics Market
10.2.6.5.1 United Kingdom Neurodiagnostics Market by Product
10.2.6.5.2 United Kingdom Neurodiagnostics Market by Indication
10.2.6.5.3 United Kingdom Neurodiagnostics Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Neurodiagnostics Market Overview
10.3.2 Asia-Pacific Neurodiagnostics Market Forecasts and Analysis
10.3.3 Asia-Pacific Neurodiagnostics Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Neurodiagnostics Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Neurodiagnostics Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Neurodiagnostics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Neurodiagnostics Market
10.3.6.1.1 Australia Neurodiagnostics Market by Product
10.3.6.1.2 Australia Neurodiagnostics Market by Indication
10.3.6.1.3 Australia Neurodiagnostics Market by End User
10.3.6.2 China Neurodiagnostics Market
10.3.6.2.1 China Neurodiagnostics Market by Product
10.3.6.2.2 China Neurodiagnostics Market by Indication
10.3.6.2.3 China Neurodiagnostics Market by End User
10.3.6.3 India Neurodiagnostics Market
10.3.6.3.1 India Neurodiagnostics Market by Product
10.3.6.3.2 India Neurodiagnostics Market by Indication
10.3.6.3.3 India Neurodiagnostics Market by End User
10.3.6.4 Japan Neurodiagnostics Market
10.3.6.4.1 Japan Neurodiagnostics Market by Product
10.3.6.4.2 Japan Neurodiagnostics Market by Indication
10.3.6.4.3 Japan Neurodiagnostics Market by End User
10.3.6.5 South Korea Neurodiagnostics Market
10.3.6.5.1 South Korea Neurodiagnostics Market by Product
10.3.6.5.2 South Korea Neurodiagnostics Market by Indication
10.3.6.5.3 South Korea Neurodiagnostics Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Neurodiagnostics Market Overview
10.4.2 Middle East and Africa Neurodiagnostics Market Forecasts and Analysis
10.4.3 Middle East and Africa Neurodiagnostics Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Neurodiagnostics Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Neurodiagnostics Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Neurodiagnostics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Neurodiagnostics Market
10.4.6.1.1 South Africa Neurodiagnostics Market by Product
10.4.6.1.2 South Africa Neurodiagnostics Market by Indication
10.4.6.1.3 South Africa Neurodiagnostics Market by End User
10.4.6.2 Saudi Arabia Neurodiagnostics Market
10.4.6.2.1 Saudi Arabia Neurodiagnostics Market by Product
10.4.6.2.2 Saudi Arabia Neurodiagnostics Market by Indication
10.4.6.2.3 Saudi Arabia Neurodiagnostics Market by End User
10.4.6.3 U.A.E Neurodiagnostics Market
10.4.6.3.1 U.A.E Neurodiagnostics Market by Product
10.4.6.3.2 U.A.E Neurodiagnostics Market by Indication
10.4.6.3.3 U.A.E Neurodiagnostics Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Neurodiagnostics Market Overview
10.5.2 South and Central America Neurodiagnostics Market Forecasts and Analysis
10.5.3 South and Central America Neurodiagnostics Market Forecasts and Analysis - By Product
10.5.4 South and Central America Neurodiagnostics Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Neurodiagnostics Market Forecasts and Analysis - By End User
10.5.6 South and Central America Neurodiagnostics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Neurodiagnostics Market
10.5.6.1.1 Brazil Neurodiagnostics Market by Product
10.5.6.1.2 Brazil Neurodiagnostics Market by Indication
10.5.6.1.3 Brazil Neurodiagnostics Market by End User
10.5.6.2 Argentina Neurodiagnostics Market
10.5.6.2.1 Argentina Neurodiagnostics Market by Product
10.5.6.2.2 Argentina Neurodiagnostics Market by Indication
10.5.6.2.3 Argentina Neurodiagnostics Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NEURODIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. GE HEALTHCARE
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. KONINKLIJKE PHILIPS N.V.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SIEMENS HEALTHINEERS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. HITACHI, LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CANON, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NATUS MEDICAL INCORPORATED
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. F. HOFFMANN-LA ROCHE AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ADVANCED BRAIN MONITORING, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. LIFELINES NEURO
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MITSAR CO., LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. GE HEALTHCARE
2. KONINKLIJKE PHILIPS N.V
3. SIEMENS HEALTHINEERS
4. HITACHI, LTD
5. CANON, INC
6. NATUS MEDICAL INCORPORATED
7. F. HOFFMANN-LA ROCHE AG
8. ADVANCED BRAIN MONITORING, INC
9. LIFELINES NEURO
10. MITSAR CO., LTD.
TIPRE00008007
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking